Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Treatment completed in phase I study of SB-509 in diabetic neuropathy

Dec. 2, 2005

Recent patents describe novel agents for metabolic disorders

Dec. 1, 2005

LY-156735 reduces body weight, without altering food consumption

Dec. 1, 2005

Novel agents for diabetes and related complications reported in recent patent literature

Nov. 30, 2005

Obese, dyslipidemic subjects lose weight on rimonabant

Nov. 30, 2005

Agile completes phase II study for low estrogen contraceptive patch

Nov. 30, 2005

Denosumab offers long-term bone improvements in postmenopausal women

Nov. 29, 2005

EMD-336340 lowers plasma uric acid in healthy volunteers

Nov. 29, 2005

Clinical results for Diamyd due in August 2006

Nov. 29, 2005

Phase III PolyHeme trial recommended to continue

Nov. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...